Cancer immunotherapy declined Mr. Zhao’s PSA

Mr. Zhao, 51 years old male from China. Four years ago, he was diagnosed with prostate cancer with multi-metastasis to bone. His PSA value kept rising up to as high as 940.9. He never had an effective treatment until he received the DC-CTL cancer immunotherapy (dendritic cell and T cell based). During the treatment with immunotherapy, he did not have any other treatment at the same time.

Prostate Cancer

According to the test result of PSA, the PSA value decreased rapidly after receiving the cancer immunotherapy. Mr. Zhao was so surprised by this unexpected outcomes, and he was so happy.